{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:23:45Z","timestamp":1756992225761},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1988,10,1]],"date-time":"1988-10-01T00:00:00Z","timestamp":591667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1988,10]]},"DOI":"10.1378\/chest.94.4.853","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T13:25:26Z","timestamp":1194441926000},"page":"853-854","source":"Crossref","is-referenced-by-count":4,"title":["Oral Propafenone Therapy for Patients with Paroxysmal Supraventricular Tachyarrhythmia"],"prefix":"10.1016","volume":"94","author":[{"given":"Byron J.","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy R.","family":"Luckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter L.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.94.4.853_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/oxfordjournals.eurheartj.a061621","article-title":"The multiple modes of action of propafenone","volume":"5","author":"Dukes","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.94.4.853_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9149(84)90687-8","article-title":"A controlled trial of propafenone for treatment of frequent and repetitive ventricular complexes","volume":"53","author":"Salerno","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.94.4.853_bib3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/00005344-198111000-00002","article-title":"Electrophysiological and antiarrhythmic properties of propafenone in isolated cardiac preparations","volume":"3","author":"Ledda","year":"1981","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.94.4.853_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/BF00542530","article-title":"Beta-blocking and electrophysiological effects of propafenone in volunteers","volume":"25","author":"Muller-Peltzer","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.94.4.853_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/oxfordjournals.eurheartj.a061215","article-title":"Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia","volume":"2","author":"Waleffe","year":"1981","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.94.4.853_bib6","doi-asserted-by":"crossref","first-page":"29D","DOI":"10.1016\/S0002-9149(84)80283-0","article-title":"Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up","volume":"54","author":"Breithardt","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.94.4.853_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1540-8159.1984.tb05591.x","article-title":"Effects of propafenone on induction and maintenance of atrio-ventricular nodal reentrant tachycardia","volume":"7","author":"Garcia-Civera","year":"1984","journal-title":"Pace"},{"key":"10.1378\/chest.94.4.853_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9149(85)91017-3","article-title":"Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia","volume":"56","author":"Manz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.94.4.853_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-105-5-655","article-title":"Intravenous propafenone for termination of reentrant supraventricular tachycardia","volume":"105","author":"Shen","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.94.4.853_bib10","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1016\/S0002-9149(84)80288-X","article-title":"European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias","volume":"54","author":"Coumel","year":"1984","journal-title":"Am J Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216305943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216305943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T22:24:42Z","timestamp":1546467882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216305943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1988,10]]}},"alternative-id":["S0012369216305943"],"URL":"https:\/\/doi.org\/10.1378\/chest.94.4.853","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1988,10]]}}}